Fulcrum Therapeutics, Inc. · NASDAQ:FULC

BlackRock, Inc. reported a 7.20% stake in Fulcrum Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Jul 28, 2026

BlackRock, Inc. reported a 7.20% stake in Fulcrum Therapeutics, Inc., 4,802,880 shares, as a passive investor on Jun 30, 2026. Filed Jul 28, 2026 (Schedule 13G/A).

Stake
7.20%
Shares
4,802,880
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.7.20%4,802,880

Source

View original at SEC

Related